Jaberi-Douraki, M., Ramachandran, R. A., Xu, X., Mazzoni, S. A., Khouri, J., Williams, L., Valent, J. N., Samaras, C. J., Shad, Y., Anwer, F., Raza, S. (2025). Comparative assessment of colitis-related adverse events in multiple myeloma patients treated with teclistamab, ciltacabtagene, and idecabtagene: Incidence, outcomes, and risk assessment.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e19510